Skip Header

1 - 25 of 30 results for author:"Lehmann U." in Literature citations

Page of 2 | Next »

to top of page·  

Results Customize

› Repeat search in UniProtKB (3)

IPH-926 lobular breast cancer cells harbor a p53 mutant with temperature-sensitive functional activity and allow for profiling of p53-responsive genes.

Christgen M., Noskowicz M., Heil C., Schipper E., Christgen H., Geffers R., Kreipe H., Lehmann U.

Lab. Invest. 92:1635-1647(2012) · Mapped (32)

Nuclear Kaiso expression is associated with high grade and triple-negative invasive breast cancer.

Vermeulen J.F., van de Ven R.A., Ercan C., van der Groep P., van der Wall E., Bult P., Christgen M., Lehmann U., Daniel J., van Diest P.J. et al.

PLoS ONE 7:e37864-e37864(2012) · Mapped (1)

Local activation of dendritic cells alters the pathogenesis of autoimmune disease in the retina.

Heuss N.D., Lehmann U., Norbury C.C., McPherson S.W., Gregerson D.S.

J. Immunol. 188:1191-1200(2012) · Mapped (2)

ABCB1/MDR1 contributes to the anticancer drug-resistant phenotype of IPH-926 human lobular breast cancer cells.

Krech T., Scheuerer E., Geffers R., Kreipe H., Lehmann U., Christgen M.

Cancer Lett. 315:153-160(2012) · Mapped (9)

GDF-15 is abundantly expressed in plexiform lesions in patients with pulmonary arterial hypertension and affects proliferation and apoptosis of pulmonary endothelial cells.

Nickel N., Jonigk D., Kempf T., Bockmeyer C.L., Maegel L., Rische J., Laenger F., Lehmann U., Sauer C., Greer M. et al.

Respir. Res. 12:62-62(2011) · Mapped (1)

Diminished met signaling in podocytes contributes to the development of podocytopenia in transplant glomerulopathy.

Agustian P.A., Schiffer M., Gwinner W., Schafer I., Theophile K., Modde F., Bockmeyer C.L., Traeder J., Lehmann U., Grosshennig A. et al.

Am. J. Pathol. 178:2007-2019(2011) · Mapped (22)

Acute-phase protein alpha1-antitrypsin inhibits neutrophil calpain I and induces random migration.

Al-Omari M., Korenbaum E., Ballmaier M., Lehmann U., Jonigk D., Manstein D.J., Welte T., Mahadeva R., Janciauskiene S.

Mol. Med. 17:865-874(2011) · Mapped (3)

ICSBP promoter methylation in myelodysplastic syndromes and acute myeloid leukaemia.

Otto N., Manukjan G., Gohring G., Hofmann W., Scherer R., Luna J.C., Lehmann U., Ganser A., Welte K., Schlegelberger B. et al.

Leukemia 25:1202-1207(2011) · Mapped (2)

SH3TC2, a protein mutant in Charcot-Marie-Tooth neuropathy, links peripheral nerve myelination to endosomal recycling.

Stendel C., Roos A., Kleine H., Arnaud E., Ozcelik M., Sidiropoulos P.N., Zenker J., Schupfer F., Lehmann U., Sobota R.M. et al.

Brain 133:2462-2474(2010) · Mapped (4)

Obliterative airway remodelling in transplanted and non-transplanted lungs.

Jonigk D., Theophile K., Hussein K., Bock O., Lehmann U., Bockmeyer C.L., Gottlieb J., Fischer S., Simon A., Welte T. et al.

Virchows Arch. 457:369-380(2010) · Mapped (8)

Constitutional mismatch repair deficiency and childhood leukemia/lymphoma--report on a novel biallelic MSH6 mutation.

Ripperger T., Beger C., Rahner N., Sykora K.W., Bockmeyer C.L., Lehmann U., Kreipe H.H., Schlegelberger B.

Haematologica 95:841-844(2010) · Mapped (6)

Epigenetic inactivation of tumour suppressor gene KLF11 in myelodysplastic syndromes*.

Potapova A., Hasemeier B., Romermann D., Metzig K., Gohring G., Schlegelberger B., Langer F., Kreipe H., Lehmann U.

Eur. J. Haematol. 84:298-303(2010) · Mapped (4)

Expression of KAI1/CD82 in distant metastases from estrogen receptor-negative breast cancer.

Christgen M., Christgen H., Heil C., Krech T., Langer F., Kreipe H., Lehmann U.

Cancer Sci. 100:1767-1771(2009) · Mapped (2)

Chemokine receptor CCR7 contributes to a rapid and efficient clearance of lytic murine gamma-herpes virus 68 from the lung, whereas bronchus-associated lymphoid tissue harbors virus during latency.

Kocks J.R., Adler H., Danzer H., Hoffmann K., Jonigk D., Lehmann U., Forster R.

J. Immunol. 182:6861-6869(2009) · Mapped (2)

Differential roles of NHERF1, NHERF2, and PDZK1 in regulating CFTR-mediated intestinal anion secretion in mice.

Singh A.K., Riederer B., Krabbenhoft A., Rausch B., Bonhagen J., Lehmann U., de Jonge H.R., Donowitz M., Yun C., Weinman E.J. et al.

J. Clin. Invest. 119:540-550(2009) · Mapped (16)

KAI1/CD82 is a novel target of estrogen receptor-mediated gene repression and downregulated in primary human breast cancer.

Christgen M., Bruchhardt H., Ballmaier M., Krech T., Langer F., Kreipe H., Lehmann U.

Int. J. Cancer 123:2239-2246(2008) · Mapped (2)

Familial polycythemia vera with non-germline JAK2(V617F) mutation sparing the abnormal and clonal granulopoiesis.

Hussein K., Bock O., Ballmaier M., Gohring G., Steinemann D., Lehmann U., Kemper J., Buhr T., Kreipe H.

Leukemia 21:2566-2568(2007) · Mapped (6)

Promoter methylation of PARG1, a novel candidate tumor suppressor gene in mantle-cell lymphomas.

Ripperger T., von Neuhoff N., Kamphues K., Emura M., Lehmann U., Tauscher M., Schraders M., Groenen P., Skawran B., Rudolph C. et al.

Haematologica 92:460-468(2007) · UniProtKB (1)

Telomerase deletion limits progression of p53-mutant hepatocellular carcinoma with short telomeres in chronic liver disease.

Lechel A., Holstege H., Begus Y., Schienke A., Kamino K., Lehmann U., Kubicka S., Schirmacher P., Jonkers J., Rudolph K.L.

Gastroenterology 132:1465-1475(2007) · Mapped (11)

LEF-1 is crucial for neutrophil granulocytopoiesis and its expression is severely reduced in congenital neutropenia.

Skokowa J., Cario G., Uenalan M., Schambach A., Germeshausen M., Battmer K., Zeidler C., Lehmann U., Eder M., Baum C. et al.

Nat. Med. 12:1191-1197(2006) · Mapped (5)

Testing the importance of p27 degradation by the SCFskp2 pathway in murine models of lung and colon cancer.

Timmerbeul I., Garrett-Engele C.M., Kossatz U., Chen X., Firpo E., Grunwald V., Kamino K., Wilkens L., Lehmann U., Buer J. et al.

Proc. Natl. Acad. Sci. U.S.A. 103:14009-14014(2006) · Mapped (14)

An integrated strategy for identification and relative quantification of site-specific protein phosphorylation using liquid chromatography coupled to MS2/MS3.

Wolschin F., Lehmann U., Glinski M., Weckwerth W.

Rapid Commun. Mass Spectrom. 19:3626-3632(2005) · Mapped (3)

Mechanisms of SOCS3 phosphorylation upon interleukin-6 stimulation. Contributions of Src- and receptor-tyrosine kinases.

Sommer U., Schmid C., Sobota R.M., Lehmann U., Stevenson N.J., Johnston J.A., Schaper F., Heinrich P.C., Haan S.

J. Biol. Chem. 280:31478-31488(2005) · Mapped (2)

Absence of p21(CIP 1), p27(KIP 1) and p 57(KIP 2) methylation in MDS and AML.

Brakensiek K., Langer F., Kreipe H., Lehmann U.

Leuk. Res. 29:1357-1360(2005) · Mapped (9)

Down-regulation of the IGF-2/H19 locus during normal and malignant hematopoiesis is independent of the imprinting pattern.

Tessema M., Langer F., Bock O., Seltsam A., Metzig K., Hasemeier B., Kreipe H., Lehmann U.

Int. J. Oncol. 26:499-507(2005) · Mapped (3)

to top of page·

Page of 2 | Next »